Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: cannabinoids

  • Novel Psychoactive Substances of Abuse: Part I

    This issue is the first of a two-part series on new novel or designer psychoactive drugs. Many of them represent alterations of existing agents that exhibit new effects from the modification. Keep the possibility of intoxication with these agents in mind when evaluating patients with altered levels of consciousness and mentation.

  • Stimulant-Based Drugs of Abuse in the Trauma Patient

    Substance abuse is a major healthcare issue with effects on all aspects of patient care, including trauma. A large percentage of trauma patients have a positive drug screen, and acute and chronic abuse have impacts both on the acute and long-term management of these patients. This report is the first of a two-part series and focuses on stimulants and substances with sympathomimetic properties, with particular attention to the impact on the trauma patient.


  • Cannabis for Mental Health Disorders: Follow the Evidence

    In a review of 83 eligible studies, researchers found little evidence to support the efficacy of cannabinoids to treat depressive disorders, anxiety disorders, or several other mental health disorders.

  • Understanding Medical Marijuana

    This article will evaluate and assess medical marijuana, also called medical cannabis, and will cover benefits and risks, clinical considerations affecting its recommendation, and currently available evidence.

  • Cannabis for Mental Health Disorders: Follow the Evidence

    In a review of 83 eligible studies, researchers found little evidence to support the efficacy of cannabinoids to treat depressive disorders, anxiety disorders, or several other mental health disorders. There is low-grade evidence that pharmaceutical cannabis may help improve symptoms of anxiety in patients with a comorbid medical condition.

  • Cannabinoids for Pain Relief Unproven for Surgical Cases

    Surgery centers treating patients who have been using marijuana or cannabinoids for pain relief or nausea are raising questions about efficacy and side effects.

  • Deciphering Medical Marijuana

    The expansion of the sanctioned use of marijuana for recreational and medical purposes has exploded in recent years and warrants a critical appraisal of the primary care physician’s role in providing advice to and counseling patients.

  • Adverse Reactions to Cannabis and Cannabinoids

    Understanding the potential reactions that can occur from cannabis and synthetic cannabinoids can help emergency physicians recognize these effects in patients who may present to the emergency department.

  • Marijuana in Pregnancy

    A group of investigators posing as pregnant patients called marijuana dispensaries in Colorado to determine whether the stores’ staff recommended it for nausea and vomiting, if there were risks in pregnancy, and if providers should be consulted. The results were enlightening.

  • Ethics and Science, Cannabinoids and Healthcare

    Perhaps no topic is more controversial than the use of marijuana in clinical practice. Within the United States, there are an estimated 55 million recent active users, defined as one to two uses within the previous year, and 35 million regular users, defined as one to two uses per month.